Pure Trading
Go Public In Canada
CNSX Radio
CNSX Filings
CNSX Issuer Services
AnnualReport_but_En

Arch Biopartners Inc. (ACH) -
Industry:  Biotechnology
RSP Eligible:  Yes
Market Maker:  No Market Maker



All data delayed 15 minutes.
Bid Size Bid Price Ask Price Ask Size
10 0.200 0.250 60
Note: Bid Size and Ask Size fields are displayed in boardlots
 
Volume Last Price Tick Net Change
0.210 0.010
 
52 Week High 52 Week Low  
0.405 0.150





 US Patent Office Issues Biofilm Patent
 06/06/2013
 Brain Tumor Targeting Team awarded $750,000 grant
 04/22/2013
 Publishes Results Linking IBD to Key Enzyme
 04/04/2013








Date/Time Price Change Volume Buyer Seller
Jun 13, 13:46 0.210 +0.010 10,000 National Bank BMO Nesbitt
Jun 03, 09:30 0.200 -0.040 7,000 RBC BMO Nesbitt
May 23, 12:29 0.240 +0.050 2,000 RBC Canaccord
May 22, 13:10 0.190 -0.020 14,500 TD Securities BMO Nesbitt
May 22, 11:16 0.190 -0.020 4,500 National Bank TD Securities


 
Issued & Outstanding:   47,760,179
Reserved for Issuance:   350,000
Thin Float:   No


Address   27 St. Clair Ave East
 P.O. Box 305
 Toronto Ontario
 M4T 2M5
Phone   1-647-428-7031
Fax   1-905-770-4454
Email   info@archbiopartners.com
URL   http://www.archbiopartners.com
Listing Date   Friday, May 07, 2010
Auditor   EXG Chartered Accountants
Transfer Agent   Equity Financial Trust Company
Investor Relations   n/a



 Monthly Progress Report May 2013
 Montly Progress Report April 2013
 Monthly Progress Report March 2013
 Arch AGM results
 Confirmation of Mailing 2013
 Management Information Circular


RC Background
CNSX News
As an organization, we are constantly looking for ways to assist our dealers and other market participants to reduce costs and network management challenges.
>>>
CNSX announced today a new strategic partnership with Innovate Calgary and Alberta Deal Generator (ADG). Innovate Calgary and CNSX have forged a partnership agreement to enhance and support the technology and startup sector in Canada.
>>>
Issuer News
IMD-Press Release
6/17/2013